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Abstract In recent years, genome-sequencing projects of
pathogens and humans have revolutionized microbial drug
target identification. Of the several known genomic strat-
egies, subtractive genomics has been successfully utilized
for identifying microbial drug targets. The present work
demonstrates a novel genomics approach in which codon
adaptation index (CAI), a measure used to predict the
translational efficiency of a gene based on synonymous
codon usage, is coupled with subtractive genomics
approach for mining potential drug targets. The strategy
adopted is demonstrated using respiratory pathogens,
namely, Streptococcus pneumoniae and Haemophilus
influenzae as examples. Our approach identified 8 potent
target genes (Streptococcus pneumoniae–2, H. influenzae–
6), which are functionally significant and also play key role
in host-pathogen interactions. This approach facilitates
swift identification of potential drug targets, thereby
enabling the search for new inhibitors. These results
underscore the utility of CAI for enhanced in silico drug
target identification.
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Introduction
The astonishing success of genomics has delivered an
ever-increasing flow of sequence data. The sequence data
serve as the raw material for in silico target discovery
(Read et al. 2001). The strategies for drug design and
development are progressively shifting from the genetic
approach to the genomic approach (Galperin and Koonin
1999). Genomics and bioinformatics provide new
opportunities for finding optimal targets. With the phe-
nomenal growth of microbial sequence databases, it has
now become possible to use in silico comparisons among
genomes to identify potential targets at the beginning of
the drug discovery process. To date, more than 500
complete microbial genomes and human genome
sequence data have been published and are publicly
available (for an updated list of published genomes, vide
http://www.genomesonline.org/).
Genomics can be applied to assess the suitability of
potential targets using two criteria: ‘‘essentiality’’ and
‘‘selectivity’’. Essential gene products are considered to
constitute the foundation of the organism’s life, and are
therefore likely to be common to all cells (Mushegian and
Koonin 1996; Kobayashi et al. 2003; Itaya 1995). Galperin
and Koonin (1999) suggested searching for drug targets
among previously characterized proteins that are specific
and essential for a particular pathogen. Recently, Zhang
et al. (2004) compiled a list of all currently available
essential genes into the Database of Essential Genes (DEG)
comprising of several bacterial members.
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The possibilities of mining targets through genomics
protocols have been increasing. An interesting approach
named ‘‘differential genome display’’ or ‘‘subtractive
genomics’’ has been proposed for the prediction of potential
drug targets (Huynen et al. 1997; 1998). This strategy
depends on the fact that genomes of parasitic microorgan-
isms are generally much smaller and encode fewer proteins
than the genomes of free-living organisms. The genes that
are present in the genome of a parasitic microbe, but devoid
in the genome of a taxonomically related free-living
microbe, are likely to be important for its pathogenicity.
Also, this target should not exhibit any well-conserved
homolog in the human host. Hence, they may be considered
as candidate drug targets (Sakharkar et al. 2004; Dutta et al.
2006). Subtractive genomics has been successfully utilized
by several authors to locate novel drug targets in Pseudo-
monas aeruginosa (Sakharkar et al. 2004; Perumal et al.
2007), Helicobacter pylori (Dutta et al. 2006), Mycobacte-
rium tuberculosis (Anishetty et al. 2005), Neisseria species
(Sarangi et al. 2009; Barh and Kumar 2009), Burkholderia
pseudomallei (Chong et al. 2006), Salmonella typhi (Rathi
et al. 2009), Aeromonas hydrophila (Sharma et al. 2008), and
Clostridium perfringens (Chhabra et al. 2010). The pursuit
has been effectively complemented with the compilation of
the Database of Essential Genes (DEG) for several patho-
genic microorganisms (Zhang et al. 2004).
Codon usage analysis aids in identifying the selectivity
and expression levels of the genes (Bennetzen and Hall 1982;
Grosjean and Fiers 1982; Ikemura 1985; Ikemura and Ozeki
1982; Nichols et al. 1980). The codon adaptation index (CAI)
(Sharp and Li 1987) is an extensively used measure of codon
bias in prokaryotes and eukaryotes (Akashi 1994; Frohlich
and Wells 1994). It summarizes the adaptation of codon
usage in the set of genes known to be highly expressed. The
frequency of codon usage in the highly expressed genes is
used to define the relative fitness values for each synonymous
codon. These values are calculated based on Relative Syn-
onymous Codon Usage (RSCU) rather than raw codon usage
and are therefore essentially independent of amino acid
composition. Thus, CAI is defined as the geometric mean of
relative adaptiveness values.






where xk is the relative adaptedness of the kth codon, and
L is the number of synonymous codons in the gene.
The CAI values of genes in a genome range between 0
and 1. Higher CAI value usually suggests that the gene of
interest is likely to be highly expressed.
Streptococcus pneumoniae or pneumococcus is a gram-
positive, alpha-hemolytic, capsulated, lanceolate diplococ-
cus bacterium. This significant human pathogen was
recognized as a major cause of pneumonia in the late nine-
teenth century. In children, they are the most prevalent
bacterial agent in community-acquired pneumonia, otitis
media, and bacterial meningitis. They also cause sinusitis,
bronchitis, cellulitis, endocarditis, pericarditis, and bactere-
mia conditions (Ryan and Ray 2004). The genome of this
organism was sequenced by the year 2001. It is a closed,
circular DNA structure containing 2 million basepairs with a
core set of 1553 essential genes, plus 154 genes in its viru-
lome, which contribute to virulence, and 176 genes that
maintain a non-invasive phenotype. It contains 39.7% of GC
(Guanine, Cytosine) content (GenBank Acc. No. AE005672)
(Tettelin et al. 2001).
Haemophilus influenzae, first described by Richard
Pfeiffer (1892) during influenza pandemic, is a small, non-
motile, non-sporing, oxidase positive, pleomorphic, and
gram-negative bacilli. This bacterium was formerly called
Pfeiffer’s bacillus or Bacillus influenza and is exclusive
human pathogens, most strains being opportunistic. They
are characterized by their requirement of one or both of two
accessory growth factors (X and V) present in blood. It
became the first free-living organism whose small circular
genome was completely sequenced (Ryan and Ray 2004).
The sequencing project, completed and published in sci-
ence in 1995, was conducted at The Institute for Genomic
Research (TIGR). The genome is made up of 1.8 Mbp of
DNA and contains 1740 genes with a GC content of 38.1%.
(GenBank Ac. No.L42023) (Fleischmann et al. 1995).
The present work aims to utilize subtractive genomics
approach pertaining to the identification of potent drug
targets in the two respiratory pathogens, Streptococcus
pneumoniae and Haemophilus influenzae. An attenuated
subtractive genomics approach was carried out by incor-
porating codon adaptation index (CAI) to increase the
strength of prediction accuracy.
Materials and methods
Data collection
Databases primarily DEG, Kyoto Encyclopedia of Genes and
Genomes (KEGG) (Ogata et al. 1999) and tools such as
ACUA (Umashankar et al. 2007), CD-HIT, and BLAST were
employed in this study. The essential gene datasets from DEG
(version 3.0) of the two respiratory bacterial pathogens viz.
Streptococcus pneumoniae TIGR4 (110 genes) and Hae-
mophilus influenzae RdkW20 (638 genes) were utilized.
CAI calculation
The essential genesets obtained were subjected to CAI
value (Sharp and Li 1987) calculation using ACUA. The
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complete respective microbial essential genesets were used
as reference set, instead of highly expressed genes for CAI
value calculation. This selection was based on the studies
conducted by Rocha and Danchin (2004), wherein they
suggest that essential genes are highly conserved and also
tend to be more expressed than average. Non-synonymous
codons and stop codons were excluded during calculation.
Moreover, bacterial essential genes also follow a similar
pattern of codon frequencies as it has been used for
machine learning studies to classify essential genes in
bacteria (Plaimas et al. 2010).
Mining significant genes from essential geneset
Wu et al. (2005) study on Streptomyces coelicolor and
Streptomyces avermitilis demonstrated significance of CAI
value and its correlation with experimental proteomic data.
Based on this study, CAI value was chosen as a measure
for mining significant essential genes. Hence, the genes
with CAI value greater than or equal to 0.75 were segre-
gated from the essential gene datasets studied.
Selection of taxonomically related non-pathogenic
bacteria
The following organisms were selected as equivalent non-
pathogenic species of the respiratory bacterial pathogens
under study:
Streptococcus thermophilus CNRZ1066
Streptococcus thermophilus (Streptococcus salivarius
subsp. thermophilus) is a gram-positive, facultative anaer-
obic, cytochrome-, oxidase- and catalase-negative, non-
motile, non-spore forming, and homofermentative bacte-
rium. This alpha-hemolytic species of the viridans group is
classified as a thermophilic lactic acid bacterium (LAB)
and is the second most important industrial dairy starter.
This CNRZ1066 strain was isolated from yoghurt in
France. It is ‘‘Generally Recognized As Safe’’ (GRAS)
species, and more than 1021 live cells are being ingested
annually by the human population (Bolotin et al. 2004;
Hols et al. 2005). The completely sequenced genome of
this organism has 1.7 Mbp (GenBank Acc. No. CP000024)
and contains 39.1% of GC content coding 1915 proteins
(Bolotin et al. 2004).
Mannheimia succiniciproducens MBEL55E
Mannheimia succiniciproducens MBEL55E is a non-spor-
ing, mesophilic gram-negative coccobacillary bacterium. It
has been isolated from a bovine rumen. It has ability to
produce large amounts of succinic acid from several
sources. This capnophilic organism is related to H. influ-
enzae in its morphological characters, and it is non-path-
ogenic to humans (Hong et al. 2004). It has been identified
to contain single chromosome (length of 2,314,078 bp)
with no plasmid (GenBank Acc. No.AE016827). With
42.5% GC content, it also has 2384 protein-coding genes
present in it (Hong et al. 2004).
Selections of taxonomically related non-pathogenic
organisms were made based on morphological and physi-
ological equivalence to pathogens, as well as also on the
availability of the complete genome sequence.
Screening of pathogen-specific sequences
Each significant gene identified based on the CAI value
was manually annotated to IDENTIFY the protein it
encodes along with the metabolic pathway information
available from KEGG. The significant datasets obtained
were subjected to normalization using CD-HIT software to
remove duplicate protein sequences or exclude paralogs as
well as exclude proteins of less than 100 amino acid resi-
dues as described by Dutta et al. (2006). The normalized
dataset sequences were subjected to BLASTP with E-value
cutoff of 10-3 for screening significant essential protein
sets versus respective free-living organism’s proteomes to
identify the pathogen-specific sequences.
Selection of non-human homologs and potential target
identification
The obtained gene sequences were subjected to BLASTP
search against human proteome to identify proteins with no
human homology. The E-value cutoff of 10-3 was adopted
based on the study by Sakharkar et al. (2004), in which this
cutoff was used to screen human non-homolog proteins of
Pseudomonas aeruginosa. As a stringent measure, the pro-
teins with ‘‘no hits found’’ as predicted by BLASTP were
only chosen as potential drug targets and other sequences
were excluded. The potentialities of the targets were further
validated using supporting literature. Moreover, the func-
tional significance of hypothetical proteins obtained as tar-
gets was assessed using INTERPROSCAN. The complete
flowchart of the methodology adopted is shown in Fig. 1.
Results
Data collection and CAI value calculation
A total of 110 genes of Streptococcus pneumoniae TIGR4
strain were acquired from DEG database. Similarly, 638
genes of Haemophilus influenzae Rd KW20 were also
obtained from DEG. All the genes collected are known to be
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essential for the cell’s survival (as per DEG). The collected
gene sequences were segregated organism-wise and were
subjected to codon adaptation index (CAI) calculation using
ACUA. The CAI value of each gene was calculated using
respective microorganism’s essential genes codon usage
table as reference. Non-synonymous codons and stop
codons were excluded during calculation. The overall
range of CAI values shows significant variations in both
the organisms studied: H. influenzae (CAI range =
0.547–0.884), S. pneumoniae (CAI range = 0.641–0.818).
Fig. 1 Codon usage analysis
and drug target identification
workflow
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Mining significant genes from essential geneset
CAI value cutoff was chosen as a measure for mining
significant genes from the Essential Geneset based on the
study by Wu et al. (2005). They demonstrated significance
of CAI value and its correlation with experimental pro-
teomic data. CAI summarizes the adaptation of codon
usage in the set of genes known to be highly expressed.
Thus, the genes with CAI value greater than or equal to
0.75 were segregated from the essential gene datasets under
study. The identified genes were isolated from the
respective microbial datasets and were tabulated with its
corresponding functions after manual curation using
KEGG database reference. Of the 638 essential genes in
H. influenzae, only 97 genes were found to have CAI value
above 0.75 (Fig. 2a). Similarly, of the 110 essential genes
of Streptococcus pneumoniae, only 35 genes were shown
to have CAI value greater than 0.75 (Fig. 2b) and were
shortlisted as significant genes (Supplementary Table 1 and
Supplementary Table 2).
All the corresponding protein sequences coded by the
essential genes were retrieved by BATCH ENTREZ and
were stored as organism specific, individual protein data-
sets. These datasets were further normalized using CD-HIT
software to obtain a non-redundant data or exclude para-
logs as well as to exclude proteins of less than 100 amino
acid residues.
Selection of taxonomically related non-pathogenic
bacteria
Selection of taxonomically related non-pathogenic organ-
isms was made based on morphological and physiological
equivalence to pathogens, as well as on the availability of
the complete genome sequence. Hence, Streptococcus
thermophilus CNRZ1066 and Mannheimia succinici-
producens MBEL55E were selected as non-pathogenic
bacterial strains taxonomically related to Streptococcus
pneumoniae TIGR4 and Haemophilus influenzae RdkW20,
respectively.
The complete genome sequence of the Streptococcus
thermophilus strain LMG13811 (1889 genes) was also
available during this study. However, Streptococcus ther-
mophilus CNRZ1066 (1915 genes) strain was preferred due
to its higher number of genes in the genome. On the other
hand, the whole genome sequence of Mannheimia succi-
niciproducens MBEL55E was only available while
exploring for taxonomically related non-pathogenic strain
of H. influenzae. Hence, on this basis, the non-pathogenic
bacteria were selected.
Pathogen-specific sequences were identified by per-
forming BLASTP of normalized protein datasets versus
corresponding non-pathogen datasets.
Pathogen-specific sequences screening and potential
target identification
The obtained pathogen-specific sequences were further
subjected to BLASTP search against human proteome to
identify genes with no human homology. The resulting
genes and their corresponding protein products were con-
sidered as potential drug targets. The potential efficacy of
the targets was validated referring supporting literature.
Furthermore, the functional significance of hypothetical
proteins obtained as targets was assessed using INTER-
PROSCAN. The results reveal two significant genes in case
of S. pneumoniae, namely, alcohol dehydrogenase (zinc-
containing) and 2-C-methyl-D-erythritol 4-phosphate
Cytidylyltransferase (Table 1). Whereas, in case of Hae-
mophilus influenzae, six significant genes were identified,
out of which five were hypothetical proteins, namely,
HI0045, HI1627, HI1728, HI1053, HI1427 and other being
the cell filamentation protein (Table 1).
Discussion
Genome sequencing and bioinformatics have been driving
the discovery and development of novel class of antimi-
crobial compounds and could enable medical science to
keep pace with the increasing resistance of bacteria (Read
et al. (2001)). Additionally, they have given valuable
insights into the molecular mechanisms underlying several
diseases. The optimization and modulation of existing
bioinformatics strategies are likely to increase the pace and
accuracy of drug target identification. Hence, the present
study was formulated to evolve a novel strategy, which
demonstrates the utilization of codon usage genomics
coupled with subtractive genomics pertaining to potent
drug target identification.
CAI is a statistical method used to predict gene
expression levels and to analyze codon usage bias, which
refers to differences in the frequency of occurrence of
synonymous codons in coding DNA. This variation in
codon bias can also be interpreted as evidence of selective
pressure on the usage of synonymous codons. (Ermolaeva
2001; Lynn et al. 2002; Paul et al. 2008). CAI can be used
as an effective tool to screen potential drug targets as it is
directly related to selective pressure and gene expression.
During CAI calculation, the codon usage tables used as
reference set get normalized in the process of geometric
mean calculation and exclude bias arising due to sample
size. Hence, in this study, CAI was chosen as a parameter
to narrow down potential drug targets, and the observed
differences of CAI value in this study among the genes are
genuine and are true representative of selective pressure in
a gene-specific and species-specific manner. (Fig. 2a, c, b,
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d). Moreover, Wu et al. (2005) have already implemented
the CAI value cutoff of 0.75 and 0.78 in case of Strepto-
myces coelicolor and Streptomyces avermitilis to predict
the highly expressed genes and housekeeping genes. Fur-
thermore, this cutoff was also found to correlate with 2D
gel experimental results and was almost same for both the
species. Thus, this cutoff was chosen for the study.
Moreover, it is also rational to assume a stringent cutoff of
0.75, since this would avoid bias over choosing genes with
less selective pressure and also lead to identification of
most potential targets. Hence, the same was adopted and
was proven to be plausible in choosing significant genes.
Most available antibiotics target microbe’s essential
cellular processes. Essential gene products of microbial
cells are promising targets for antibacterial drugs (Zhang
et al. 2004). Targeting an essential gene necessary for
bacterial cell survival may provide an efficient way to
control infection. In this study, the essential genes of the
two respiratory bacterial pathogens: Streptococcus pneu-
moniae and Haemophilus influenzae were screened to
identify significant drug targets based on the codon usage
genomics coupled with subtractive genomics approach.
In the initial step of codon usage genomics, the overall
range of CAI values in the entire datasets showed significant
variations: H. influenzae (CAI = 0.547–0.884), S. pneumo-
niae (CAI = 0.641–0.818), exposing the probable selective
pressure among essential genes in an organism-specific
manner. In the next step, the significant genes were identified
and isolated from the respective microbial essential gene
datasets based on their CAI value ([ = 0.75).
Identified significant genesets were tabulated with its
corresponding functions after manual curation by KEGG
Fig. 2 Frequency of significant genes with CAI value above 0.75 in
Haemophilus influenzae (a) and Streptococcus pneumoniae (b), CAI
frequency of complete datasets: H. influenzae (c) and Streptococcus
pneumoiae, Number in boxes over bar indicates the frequency. A total
of 97 out of 638 and 35 out of 110 were identified as significant genes
in H. influenzae and S. pneumoniae, respectively
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database reference (Supplementary Table 1 and Supple-
mentary Table 2). The results reveal that H. influenzae and
S. pneumoniae contained 97 and 35 significant genes,
respectively. These significant genes probably are highly
expressed due to selective pressure by means of high
synonymous codon usage and subsequent translational
selection. Hence, the possibility of these genes being
essential for the survival of the cell is higher. The data
obtained in this study also indicate that the genes identified
as significant and were found to code for processes such as
aminoacid synthesis, energy metabolism, fatty acid syn-
thesis, nucleotide synthesis, which are obviously significant
and play a crucial role in cellular processes: central dogma,
energy metabolism, macromolecular transport, membrane
formation, pathogenicity, and cell viability. Thus, this
finding infers the predictive accuracy of the methodology
adopted. Furthermore, deciphering the functional status
of the unknown protein genes, hypothetical proteins,




Gene product Organism Interproscan prediction Functional significance Host-pathogen interactions
NP_345734.1 Alcohol dehydrogenase,
Zinc-containing
S. pneumoniae Not required Modulation of ZN? Maintenance of the intracellular
homeostasis of Zn? ions is
important







S. pneumoniae Not required Isoprenoid biosynthesis,
essential for cell
viability and virulence
Isoprenoids are localized in
membrane of S. pneumoniae and
membrane components and
essential for exhibiting virulence























The airway colonization of H.
influenzae in host is facilitated by
fimbria (Read et al. 1992; Van
Alphen and van Ham 1994)
NP_439869.1 Hypothetical protein
HI1728






Metal ion transporters Metal ion transport plays a key role
in pathogenesis in the host















Periplasmic proteins mediate non-
pilus adhesins attachment to
human epithelial cells, an
essential step during colonization




H. influenzae Not required Cell division and
chromosome
partitioning
Filamentation proteins also play an
important role in non-beta
lactamase mediated beta-lactam
resistance in H. influenzae despite
serotype, origin of isolation, or
geographic distribution (Clairoux
et al. 1992)
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predicted coding region, and unclassified proteins reported
as significant genes in this study by experimental methods
would reveal about the level of essentiality. Moreover,
these genes could also prove to be good targets as it formed
the part of dataset retrieved while mining significant genes
from essential genesets.
Subtractive genomics analysis of taxonomically related
microorganisms (pathogen vs. non-pathogens) yields a
wide range of targets with varied selective pressure,
whereas in case of closely related species it is more likely
to be narrow range of targets comprising mostly of virulent
factors, excluding the genes which are crucial for patho-
gen’s survival. Moreover, many of the well-documented
subtractive genomics studies have successfully imple-
mented the strategy of using taxonomically related
microorganisms for drug target identification, therefore the
same was implemented in this study and is proven to be
effective (Sakharkar et al. 2004; Anishetty et al. 2005).
A potent microbial drug target should not share any
well-conserved homolog in the host. Thus, a stringent
E-value cutoff of 10-3 was adopted based on the study by
Sakharkar et al. (2004), wherein this cutoff was imple-
mented to screen human non-homolog proteins in Pseu-
domonas aeruginosa. Hence, the proteins with ‘‘no hits
found’’ as predicted by BLASTP were only chosen as
potential drug targets in this study. Moreover, the same
procedure was already proven to be potent by Anishetty
et al. (2005) in mining non-pathogenic non-homologous
sequences.
In the subtractive genomics step, the results show a total
of eight significant genes (S. pnuemoniae–two, H.influen-
zae–six) that were non-homologous- to non-pathogenic-
related bacteria as well as human genes (Table 1). Alcohol
dehydrogenase (zinc-containing) (Acc. No. NP_345734.1)
of S. pneumoniae is involved in the modulation of zinc
ions. In 2007, Kloosterman et al. have reported that this
enzyme is important for bacterial virulence and their host
interaction, as it is necessary for maintenance of the
intracellular homeostasis of zinc ions. The other potential
target identified as follows: 2-C-methyl-D-erythritol
4-phosphate cytidylyltransferase (Acc. No. NP_345735.1)
is involved in isoprenoid biosynthesis of S. pneumoniae.
Isoprenoids are localized in membrane and membrane
components of S. pneumoniae and essential for exhibiting
virulence in host (Wilding et al. 2000). Both the identified
targets are essential for cell viability and virulence.
In H. influenzae, six significant genes were identified as
potential targets. Five were hypothetical proteins namely
HI0045, HI1627, HI1728, HI1053, and HI1427 and a cell
filamentation protein (Table 1). Cell filamentation protein
(Acc. No. NP_439140.1) is involved in cell division and
chromosome partitioning. Clairoux et al. (1992) have
previously reported that filamentation proteins play an
important role in non-beta lactamase-mediated beta-lactam
resistance in H. influenzae despite serotype, origin of iso-
lation, or geographic distribution. Hypothetical proteins
obtained as targets were subjected to Interproscan func-
tional annotation. Hypothetical protein HI1627 (Acc. no.
NP_439769.1) was predicted to be an endoribonuclease/
chorism_mut-like, yjgf/chorismate_mutase-like protein.
This protein is supposed to have role in the modulation of
fimbria expression genes, PUR and ILE, and inhibit their
translation. The airway colonization of H. influenzae in
host is facilitated by fimbria (Read et al. 1992; Van Alphen
and van Ham 1994). This hypothetical protein may even
serve as mammalian tumor-associated antigen.
Interproscan of the hypothetical protein HI1728 (Acc. No.
NP_439869.1) predicts it to be a natural resistance-associ-
ated macrophage protein associated with bacterial mem-
brane. Functionally, they are metal ion transporters. Metal
ion transport plays a key role in pathogenesis in the host
(Agranoff and Krishna 1998). The identified hypothetical
protein HI1427 (Acc. No. NP_439576.1) of H. influenzae is
unintegrated, putative periplasmic-binding protein CBIK. It
is predicted to be a functional significant periplasmic inter-
mediate molecule. Literature study indicates that periplas-
mic proteins mediate non-pilus adhesins attachment to
human epithelial cells and is an essential step during colo-
nization of H. influenzae (St Geme and Grass 1998).
Out of 8 finalized targets, 6 were found to be highly
potential targets with well-proven role in host-pathogen
interactions and functional significance. Proper annotations
could not be performed for the other 2 hypothetical pro-
teins due to limited literature availability. Furthermore,
these hypothetical proteins are essential genes as per DEG,
so research on these genes using modern molecular biology
shall pave way to better understand their potentiality as
efficient drug targets.
Subtractive genomics approach has been utilized by
several scientists to identify potential drug targets in many
bacteria (Sakharkar et al. 2004; Perumal et al. 2007; Dutta
et al. 2006; Anishetty et al. 2005; Sarangi et al. 2009; Barh
and Kumar 2009; Chong et al. 2006; Rathi et al. 2009;
Sharma et al. 2008; Chhabra et al. 2010). However, the
present work has employed a different novel approach,
which the previous workers have not attempted. Here, the
significant essential genes were selected based on CAI
values before performing subtractive genomics, and the
results obtained also indicate that this strategy would
enhance the predictive accuracy of current approaches.
Thus, from the above-discussed results, it could be con-
cluded that the approach used in this study could prove to
be a powerful tool toward identification of significant
essential genes in bacteria, with reasonable accuracy.
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